Principal Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.17M Buy
21,134
+175
+0.8% +$64.9K 0.1% 184
2026
Q1
$6.14M Buy
20,959
+2,110
+11% +$693K 0.09% 210
2025
Q4
$6.61M Sell
18,849
-2,951
-14% -$997K 0.1% 189
2025
Q3
$7.04M Buy
21,800
+1,465
+7% +$456K 0.12% 166
2025
Q2
$7.91M Buy
20,335
+1,961
+11% +$789K 0.15% 136
2025
Q1
$6.78M Hold
18,374
0.15% 133
2024
Q4
$6.78M Buy
18,374
+2,475
+16% +$1.04M 0.15% 132
2024
Q3
$8.27M Buy
15,899
+2,369
+18% +$1.27M 0.2% 95
2024
Q2
$7.33M Buy
13,530
+2,097
+18% +$1.11M 0.2% 92
2024
Q1
$5.93M Buy
11,433
+1,149
+11% +$571K 0.18% 112
2023
Q4
$4.85M Buy
+10,284
New +$4.76M 0.18% 115

Other funds holding ELV

Principal Securities's ELV Position: Q2 2026 in Review

Principal Securities increased its Elevance Health (ELV) stake by 0.83% in Q2 2026, buying an estimated $64.9K and bringing the position to 21,134 shares worth $8.17M. The position accounts for 0.1% of the portfolio, ranked #184.

Principal Securities first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.27M in Q3 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Principal Securities held 21,134 shares of Elevance Health worth $8.17M as of Q2 2026.
  • Principal Securities bought 175 Elevance Health shares in Q2 2026, an estimated $64.9K.
  • Elevance Health made up 0.1% of Principal Securities's portfolio in Q2 2026, its #184 holding.
  • Principal Securities first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Principal Securities's Elevance Health position peaked at $8.27M in Q3 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.